marketing-medtech

**Founder:** Pascale Chollet (née Eyrolles) — Présidente (SAS), founder
**Background:** clinician | verified: False — Unknown / not verifiable from accessible sources. No real source was found that confirms Pascale Chollet (née Eyrolles), Présidente of TOTE MEDICAL, has a clinician background. The only "clinician" matches are for a different, unrelated person — Dr. Pascale Chollet, an ophthalmologist in Agen, France — with no evidence tying that doctor to TOTE MEDICAL or to the maiden name "Eyrolles." Treating them as the same person would be an unsupported conflation. A business-registry profile matching the name (Pascale Eyrolles "CHOLLET DENEUVILLE", born 1962-07) exists on Pappers but indicates only generic company-director/administrative roles in its search snippet, no clinical/medical training, and did not clearly surface a TOTE MEDICAL link; the page itself returned HTTP 403 and could not be read.
**Stage / fundraise:** Pre-seed / earliest stage. SAS incorporated 19 Sept 2025 (~9 months old as of June 2026), 0 employees, single establishment, NAF 62.01Z (computer programming). No website, no public product, no press footprint. / None confirmed.
**Regulatory trigger:** Inferred only, not confirmed. NAF 62.01Z + company name "MEDICAL" + a clinician founder point to medical software, which would likely fall under MDR / IEC 62304 / CE marking if it qualifies as SaMD. No product scope, intended-use, or device classification has been published, so the regulatory path is unverified.
**Email:** (confidence none) — No company website, no domain, and no published email address found for TOTE MEDICAL. No verifiable email pattern exists. Not fabricating one. A clinic phone for Dr Pascale Chollet (Clinique Esquirol Saint Hilaire, Agen: 05 53 69 97 36) is published via ELSAN but is the medical practice line, not a company contact.
**LinkedIn:** **Website:**
**Score:** 7 -> Tier B
**Hook:** A brand-new (Sept 2025) medical-software venture led, in all likelihood, by a practising ophthalmologist — deep clinical domain, no visible engineering team or CTO. That is exactly OmDev's sweet spot: we drop in senior devs + AI + a dedicated CTO at a fixed monthly price (~3x cheaper than hiring the team in-house), the client owns all the code, and our pipeline produces the IEC 62304 / MDR compliance evidence (signed SOUP register at every build, requirements→code→test traceability) a SaMD will eventually need — so she can stay focused on the clinical product instead of recruiting a tech team from scratch.

---

## Founder & background
Founder/Présidente is **Pascale Marie Chollet (née Eyrolles), born 1962**, per the company registry ([recherche-entreprises](https://recherche-entreprises.api.gouv.fr/search?q=992253179)).
The same person (Pascale Eyrolles, b. July 1962) is a director of the Agen ophthalmology cost-sharing SCM **"CHOLLET DENEUVILLE (DAURIN)"** alongside ophthalmologist Sylvie Deneuville ([Pappers](https://www.pappers.fr/dirigeant/pascale_eyrolles_1962-07), [societe.com](https://www.societe.com/societe/chollet-deneuville-402114193.html)).
A **Dr Pascale Chollet, ophtalmologue** practises in Agen (ELSAN / Clinique Esquirol Saint Hilaire) ([elsan.care](https://www.elsan.care/fr/praticien/ophtalmologue/chollet-pascale)) — name, birth year and shared Agen ophthalmology structure strongly indicate a **clinician-founder** (non-technical, domain-driven). No finance/insurance background.
**Why OmDev fits:** a domain-deep clinician who will need engineers, not a co-founder hunt.

## Funding & momentum
SAS **incorporated 19 Sept 2025** — roughly 9 months old, the earliest possible stage ([registry](https://recherche-entreprises.api.gouv.fr/search?q=992253179)).
**No fundraising confirmed:** no Bpifrance/i-Lab/i-Nov grant, investor, or press signal located.
Zero declared employees, single establishment in Saint-Denis (La Réunion, 97400) — note the founder's clinical practice is in Agen, so the address may be a domiciliation.
**Why OmDev fits:** at fixed monthly price (~3x cheaper than in-house) she can build before a raise instead of after.

## Product & regulatory
**Product unannounced** — registered NAF 62.01Z (software development) under the name "TOTE MEDICAL"; no website or product description found.
Name + activity + likely ophthalmologist founder suggest a **medical / ophthalmology software** play (plausibly SaMD), but the scope is unverified.
If it qualifies as SaMD, an **IEC 62304 / MDR / CE** path lies ahead — inferred, not confirmed; no intended-use or device class is public.
**Why OmDev fits:** our pipeline emits the IEC 62304/MDR evidence (signed SOUP register per build, requirements→code→test traceability) a SaMD file needs.

## Pain & buying signals
**Solo, non-technical founder with no visible CTO or dev team** and 0 employees — a clear domain-expert-without-engineering gap.
**No digital presence yet** (no site/app), i.e. a true build-from-zero moment where a tech partner can shape the foundation.
All signals are registry-level/early; no hiring posts or agency-dependence observed, and **no published email/LinkedIn** (reach is the weak point — likely via the Agen clinic).
**Why OmDev fits:** drop-in senior devs + dedicated CTO at fixed price, client owns the code — exactly what a solo clinician-founder lacks.

---
**Sources:** https://recherche-entreprises.api.gouv.fr/search?q=992253179 · https://www.pappers.fr/dirigeant/pascale_eyrolles_1962-07 · https://www.societe.com/societe/chollet-deneuville-402114193.html · https://www.manageo.fr/entreprises/402114193.html · https://www.elsan.care/fr/praticien/ophtalmologue/chollet-pascale · https://www.doctolib.fr/ophtalmologue/agen/pascale-chollet · https://annuairesante.ameli.fr/professionnels-de-sante/fiche-detaillee-chollet-pascale-BLU1kjM3NTax